ATE174930T1 - Impfstoff, der eine untereinheit des menschlichen transferrin-rezeptors von neisseria meningitidis enthält - Google Patents

Impfstoff, der eine untereinheit des menschlichen transferrin-rezeptors von neisseria meningitidis enthält

Info

Publication number
ATE174930T1
ATE174930T1 AT92921587T AT92921587T ATE174930T1 AT E174930 T1 ATE174930 T1 AT E174930T1 AT 92921587 T AT92921587 T AT 92921587T AT 92921587 T AT92921587 T AT 92921587T AT E174930 T1 ATE174930 T1 AT E174930T1
Authority
AT
Austria
Prior art keywords
subunit
pct
transferrin receptor
human transferrin
neisseria meningitidis
Prior art date
Application number
AT92921587T
Other languages
English (en)
Inventor
Marie-Jose Quentin-Millet
Ling Lissolo
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Application granted granted Critical
Publication of ATE174930T1 publication Critical patent/ATE174930T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/871—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92921587T 1991-10-03 1992-09-29 Impfstoff, der eine untereinheit des menschlichen transferrin-rezeptors von neisseria meningitidis enthält ATE174930T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9112176A FR2682114B1 (fr) 1991-10-03 1991-10-03 Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.

Publications (1)

Publication Number Publication Date
ATE174930T1 true ATE174930T1 (de) 1999-01-15

Family

ID=9417548

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921587T ATE174930T1 (de) 1991-10-03 1992-09-29 Impfstoff, der eine untereinheit des menschlichen transferrin-rezeptors von neisseria meningitidis enthält

Country Status (15)

Country Link
US (2) US5618540A (de)
EP (1) EP0560969B1 (de)
JP (1) JPH06503364A (de)
AT (1) ATE174930T1 (de)
AU (1) AU668522B2 (de)
CA (1) CA2096411A1 (de)
DE (1) DE69227984T2 (de)
DK (1) DK0560969T3 (de)
ES (1) ES2128358T3 (de)
FI (1) FI107262B (de)
FR (1) FR2682114B1 (de)
GR (1) GR3029580T3 (de)
HU (1) HU219762B (de)
NO (1) NO309865B1 (de)
WO (1) WO1993007172A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
DE69418699T2 (de) * 1993-01-11 1999-09-30 Dana-Farber Cancer Institute, Boston Induktion der antworten zytotoxischer t-lymphozyten
ES2270420T3 (es) * 1993-11-08 2007-04-01 Sanofi Pasteur Limited Genes receptores de la transferrina de haemophilus.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
WO2000042193A1 (en) * 1999-01-15 2000-07-20 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigen
WO2010130898A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
WO2011024072A2 (en) * 2009-08-27 2011-03-03 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
CA2931685C (en) 2013-12-02 2021-09-07 Anthony B. Schryvers Immunogenic compositions and vaccines derived from bacterial surface receptor proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
DE69133334T2 (de) * 1990-08-23 2004-05-13 University Of North Carolina At Chapel Hill Transferrin bindende proteine aus neisseria-gonorrhoeae und neisseria-meningitidis
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.

Also Published As

Publication number Publication date
FR2682114B1 (fr) 1996-02-23
EP0560969A1 (de) 1993-09-22
ES2128358T3 (es) 1999-05-16
FI932490L (fi) 1993-06-01
CA2096411A1 (en) 1993-04-04
NO309865B1 (no) 2001-04-09
HUT69929A (en) 1995-09-28
US5618540A (en) 1997-04-08
WO1993007172A1 (fr) 1993-04-15
NO932009L (no) 1993-07-20
FI107262B (fi) 2001-06-29
NO932009D0 (no) 1993-06-02
AU668522B2 (en) 1996-05-09
HU9301631D0 (en) 1993-10-28
GR3029580T3 (en) 1999-06-30
FI932490A0 (fi) 1993-06-01
US5928650A (en) 1999-07-27
DE69227984T2 (de) 1999-05-12
AU2764092A (en) 1993-05-03
DK0560969T3 (da) 1999-08-23
HU219762B (hu) 2001-07-30
JPH06503364A (ja) 1994-04-14
DE69227984D1 (de) 1999-02-04
FR2682114A1 (fr) 1993-04-09
EP0560969B1 (de) 1998-12-23

Similar Documents

Publication Publication Date Title
FR2682041B1 (fr) Vaccin contre les infections a neisseria meningitidis.
FI960102A0 (fi) Uusi farmaseuttinen seos
FI963398A0 (fi) Kielenalainen tai poskensisäinen farmaseuttinen koostumus
IL116083A (en) Liquid pharmaceutical compositions containing ondanseteron and sorbitol as sweetener
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
UA41297C2 (uk) Похідні індолу, фармацевтична композиція і спосіб лікування
NO981436D0 (no) Farmasöytiske angiostatiske dipeptidsammensetninger og anvendelse derav
DE69227984D1 (de) Impfstoff, der eine Untereinheit des menschlichen Transferrin-Rezeptors von Neisseria meningitidis enthält
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
DE69217554D1 (de) Ebastin oder ebastin-analoga enthaltende arzneimittel
DK0623138T3 (da) Nye adenosinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf
IL108750A (en) Pharmaceutical cognition enhancing compositions containing 1,3-dialiphatic-8-(phenylalkyl or ludanyl) xanthines as selective adenosine receptor agents
DE69002946D1 (de) Paracetamol enthaltende arzneizubereitung.
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
GB9015774D0 (en) Novel treatment

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification